Ken Griffin Rockwell Medical, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 11,000 shares of RMTI stock, worth $45,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,000
Previous 9,200
19.57%
Holding current value
$45,430
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RMTI
# of Institutions
44Shares Held
6.35MCall Options Held
11KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY3.22MShares$13.3 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.12MShares$4.62 Million0.0% of portfolio
-
Perkins Capital Management Inc350KShares$1.45 Million1.37% of portfolio
-
Geode Capital Management, LLC Boston, MA305KShares$1.26 Million0.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI277KShares$1.14 Million0.99% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $44.1M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...